Boothbay Fund Management, LLC Intellia Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $228,476 - $452,382	-5,936 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $345,890 - $706,324	5,936 New	5,936 $431,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $276,539 - $567,724	-24,824 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.44 - $15.58 $234,338 - $386,757	24,824 New	24,824 $304,000
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $105,562 - $251,440	-9,268 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$25.78 - $32.6 $238,929 - $302,136	9,268 New	9,268 $265,000

321

87.9M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.24B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.